The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

It’s always a good sign when a couple of big deals are announced right before the conference, and this year we saw a doozie ...

One of the U.S. biotech industry’s preferred partners in China, Jiangsu Hengrui, emphasized its global ambitions and plans ...

At the JPMorgan Healthcare Conference, the European healthcare giant ... vaccine challenges from external pressures in the US and China. The Brentford, U.K.-based company remains confident that ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

CFO Aradhana Sarin outlined AstraZeneca’s plans at the 2025 JP Morgan Healthcare Conference in San Francisco on 15 January. The company maintains a confident outlook for the new year, said Sarin, ...

Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ...

I am liking what i'm seeing at the JPMorgan Healthcare Conference, says Jim Cramer Massive and dense structures have been discovered beneath the surface of Mars, leaving experts intrigued. 'Mad Money' ...

CEO Christian Behrenbruch described the Australian company’s success in a presentation at the 2025 JP Morgan Healthcare Conference on ... studies completed in China and underway in Japan.

Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...